Solid Earnings Reflect Mingchen HealthLtd's (SZSE:002919) Strength As A Business
Solid Earnings Reflect Mingchen HealthLtd's (SZSE:002919) Strength As A Business
Even though Mingchen Health Co.,Ltd.'s (SZSE:002919) recent earnings release was robust, the market didn't seem to notice. Our analysis suggests that investors might be missing some promising details.
尽管明晨健康有限公司, Ltd. 's(SZSE:002919)最近的财报表现强劲,市场似乎没有注意到。我们的分析表明,投资者可能遗漏了一些令人鼓舞的细节。
![earnings-and-revenue-history](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240505/0-b098a52c2f131e23d9fdebd2f8980c2b-0-e7bfa764008e043bfaa10c6399661329.png/big)
How Do Unusual Items Influence Profit?
不寻常的物品如何影响利润?
Importantly, our data indicates that Mingchen HealthLtd's profit was reduced by CN¥30m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Mingchen HealthLtd to produce a higher profit next year, all else being equal.
重要的是,我们的数据表明,由于不寻常的项目,明晨健康有限公司的利润比去年减少了3000万元人民币。看到不寻常的项目使公司利润付出代价从来都不是一件好事,但从好的方面来看,情况可能迟早会好转。当我们分析全球绝大多数上市公司时,我们发现重大不寻常的事项往往不会重演。而且,毕竟,这正是会计术语的含义。假设这些不寻常的支出不会再次出现,因此,我们预计明晨健康有限公司在其他条件相同的情况下,明年将实现更高的利润。
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Mingchen HealthLtd.
注意:我们始终建议投资者检查资产负债表的实力。点击此处查看我们对Mingchen HealthLtd的资产负债表分析
Our Take On Mingchen HealthLtd's Profit Performance
我们对明晨健康有限公司盈利表现的看法
Because unusual items detracted from Mingchen HealthLtd's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Based on this observation, we consider it likely that Mingchen HealthLtd's statutory profit actually understates its earnings potential! And the EPS is up 28% over the last twelve months. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. You'd be interested to know, that we found 1 warning sign for Mingchen HealthLtd and you'll want to know about this.
由于不寻常的项目削弱了明晨健康有限公司去年的收益,你可能会争辩说,我们可以预期本季度的业绩会有所改善。基于这一观察,我们认为明晨健康有限公司的法定利润可能实际上低估了其盈利潜力!在过去的十二个月中,每股收益增长了28%。本文的目标是评估我们在多大程度上可以依靠法定收益来反映公司的潜力,但还有很多需要考虑的地方。考虑到这一点,除非我们对风险有透彻的了解,否则我们不会考虑投资股票。你可能会有兴趣知道,我们找到了 Mingchen HealthLtd 的 1 个警告标志,你会想知道的。
This note has only looked at a single factor that sheds light on the nature of Mingchen HealthLtd's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
这份报告只考虑了揭示明晨健康有限公司利润性质的单一因素。但是,还有很多其他方法可以让你对公司的看法。例如,许多人认为高股本回报率是有利的商业经济的标志,而另一些人则喜欢 “关注资金”,寻找内部人士正在买入的股票。因此,你可能希望看到这份免费收藏的拥有高股本回报率的公司,或者这份内部人士正在购买的股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。